Recombinant Zika NS1 Protein

<strong>Recombinant Zika NS1 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2012357_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Zika NS1 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Modhiran N, Song H, Liu L, Bletchly C, Brillault L, Amarilla AA, Xu X, Qi J, Chai Y, Cheung STM, Traves R, Setoh YX, Bibby S, Scott CAP, Freney ME, Newton ND, Khromykh AA, Chappell KJ, Muller DA, Stacey KJ, Landsberg MJ, Shi Y, Gao GF, Young PR, Watterson D. A broadly protective antibody that targets the flavivirus NS1 protein Science. 2021 Jan 8;371(6525):190-194._x000D_ 2: Ahmad N, Badshah SL, Junaid M, Ur Rehman A, Muhammad A, Khan K. Structural insights into the Zika virus NS1 protein inhibition using a computational approach J Biomol Struct Dyn. 2021 May;39(8):3004-3011._x000D_ 3: Yu L, Liu X, Ye X, Su W, Zhang X, Deng W, Luo J, Xiang M, Guo W, Zhang S, Xu W, Yan Q, Wang Q, Cui Y, Wu C, Guo W, Niu X, Zhang F, Lei C, Qu L, Chen L, Feng L. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fcγ Receptor-Dependent and -Independent Pathways mBio. 2021 Feb 9;12(1):e03179-20._x000D_ 4: Cavazzoni CB, Bozza VBT, Lucas TCV, Conde L, Maia B, Mesin L, Schiepers A, Ersching J, Neris RLS, Conde JN, Coelho DR, Lima TM, Alvim RGF, Castilho LR, de Paula Neto HA, Mohana-Borges R, Assunção-Miranda I, Nobrega A, Victora GD, Vale AM. The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to self J Exp Med. 2021 Sep 6;218(9):e20210580._x000D_ 5: Liu Y, Liu J, Du S, Shan C, Nie K, Zhang R, Li XF, Zhang R, Wang T, Qin CF, Wang P, Shi PY, Cheng G. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes Nature. 2017 May 25;545(7655):482-486._x000D_ 6: Roldán JS, Cassola A, Castillo DS. Optimization of recombinant Zika virus NS1 protein secretion from HEK293 cells Biotechnol Rep (Amst). 2020 Feb 11;25:e00434._x000D_ 7: Lin HH, Yip BS, Huang LM, Wu SC. Zika virus structural biology and progress in vaccine development Biotechnol Adv. 2018 Jan-Feb;36(1):47-53._x000D_ 8: Biering SB, Akey DL, Wong MP, Brown WC, Lo NTN, Puerta-Guardo H, Tramontini Gomes de Sousa F, Wang C, Konwerski JR, Espinosa DA, Bockhaus NJ, Glasner DR, Li J, Blanc SF, Juan EY, Elledge SJ, Mina MJ, Beatty PR, Smith JL, Harris E. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction Science. 2021 Jan 8;371(6525):194-200._x000D_ 9: Andreata-Santos R, Pereira SS, Pereira LR, Félix AC, Romano CM, Ferreira LCS. Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein Int J Infect Dis. 2020 Jun;95:276-278._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33651942">10: Poveda-Cuevas SA, Barroso da Silva FL, Etchebest C. How the Strain Origin of Zika Virus NS1 Protein Impacts Its Dynamics and Implications to Their Differential Virulence J Chem Inf Model. 2021 Mar 22;61(3):1516-1530. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Zika NS1 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>